Medical device regulations – the future in the United Kingdom
The MHRA is inviting members of the public to participate in a consultation to provide views on possible changes to the regulatory framework for medical devices in the UK.
Protecting the UK medicines supply chain
Under good distribution practice (GDP), distributors of medicinal products have a key responsibility in preventing falsified medicines entering the legal supply chain. Weak due diligence checks on customers and suppliers increases the risk of falsified medicines entering the legal supply chain and causing serious risk to public health.